ESPI/EBI - komunikaty giełdowe

Insider trading disclosure of June, 1 2018 received by Ognian Donev

Interim condensed consolidated financial statements for the three-month period ending March, 31 2018

Termination of the previous and start a new transformation procedure through the merger of Unipharm AD into Sopharma AD

Sales revenues for April 2018

Invitation and materials for the General meeting of shareholders of Sopharma AD

Issued refusal by the Registry Agency on the transformation through merger between Sopharma AD and Unipharm AD

Annual audited consolidated financial report for 2017

Financial report for the period ending 31.03.2018

Notification concerning the General Meeting of Shareholders of Sopharma AD

Sales revenues for March 2018